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Abstract
Background: The aim of the study is to examine the effect of limited and prolonged hyperoxia on neonatal rat
lung. This is done by examining the morphologic changes of apoptosis, the expression of ceramide, an important
mediator of apoptosis, the expression of inflammatory mediators represented by IL-1β and the expression of 2
proto-oncogenes that appear to modulate apoptosis (Bax and Bcl-2).
Methods: Newborn rats were placed in chambers containing room air or oxygen above 90% for 7 days. The rats
were sacrificed at 3, 7 or 14 days and their lungs removed. Sections were fixed, subjected to TUNEL, Hoechst,
and E-Cadherin Staining. Sections were also incubated with anti-Bcl-2 and anti-Bax antisera. Bcl-2 and Bax were
quantitated by immunohistochemistry. Lipids were extracted, and ceramide measured through a modified
diacylglycerol kinase assay. RT-PCR was utilized to assess IL-1β expression.
Results: TUNEL staining showed significant apoptosis in the hyperoxia-exposed lungs at 3 days only. Co-staining
of the apoptotic cells with Hoechst, and E-Cadherin indicated that apoptotic cells were mainly epithelial cells. The
expression of Bax and ceramide was significantly higher in the hyperoxia-exposed lungs at 3 and 14 days of age,
but not at 7 days. Bcl-2 was significantly elevated in the hyperoxia-exposed lungs at 3 and 14 days. IL-1β expression
was significantly increased at 14 days.
Conclusion: Exposure of neonatal rat lung to hyperoxia results in early apoptosis documented by TUNEL assay.
The early rise in Bax and ceramide appears to overcome the anti-apoptotic activity of Bcl-2. Further exposure
did not result in late apoptotic changes. This suggests that apoptotic response to hyperoxia is time sensitive.
Prolonged hyperoxia results in acute lung injury and the shifting balance of ceramide, Bax and Bcl-2 may be related
to the evolution of the inflammatory process.
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Background
Oxygen supplement is used in different therapeutic inter-
ventions. Respiratory diseases in neonates such as hyaline
membrane disease and persistent pulmonary hyperten-
sion often require high concentrations of supplemental
oxygen. Such concentrations are known to cause cellular
damage and death in lungs and other organs as well. Cell
death secondary to hyperoxia occurs via two mechanisms:
cell necrosis and apoptosis [1,2].
Cell necrosis is a mode of cell death that occurs exclusively
in environmental disruption under nonphysiological
conditions, resulting in inflammatory reactions caused by
cell lysis and release of intracellular contents in the extra-
cellular space [3]. Necrosis is always pathological.
Apoptosis or programmed cell death is a gene-regulated
process in which a coordinated series of morphological
changes such as nucleus and chromatin condensation, cell
membrane blebbing and fragmentation of the cell into
membrane-bound apoptotic bodies occurs, resulting in
cell death [4]. The apoptotic process appears to be regu-
lated by a number of substances that include the sphingol-
ipid ceramide, a sphingolipid breakdown product [5,6]
and members of the Bcl-2 family of proteins. Bcl-2 family
members determine cell death and survival by controlling
mitochondrial membrane ion permeability, cytochrome c
release, and the subsequent activation of caspase (caspase
3, caspase 9) executor functions [7]. The Bcl-2 family of
proteins consists of pro-apoptotic (Bax, Bcl-Xs, Bak and
Bad) and anti-apoptotic (Bcl-2, Bcl-XL and Bcl-w) proteins
[8]. The role of Bcl-2 family members in response to
hypoxia has been studied in several models. Jonas et al [9]
found that minutes of hypoxia trigger the opening of large
multi-conductance channels of the outer mitochondrial
membranes inside the presynaptic terminal of a squid
giant synapse. ZVAD, wide-spectrum caspase inhibitor,
inhibits proteolysis of BCL-xL during hypoxia and pre-
vents the appearance of the hypoxia-induced channels.
Similarly, Yamamoto et al [10] demonstrated the pro-
apoptotic mechanisms of hypoxia in epithelial cells by
noticing a significant decrease in Bcl-2 and Bcl-xL, which
protects cells from apoptosis. Bax, which promotes apop-
tosis, was translocated from the cytoplasm to the mito-
chondrial membrane in response to hypoxia. While there
is interest as to the function of the Bcl-2 family members
in hypoxia-induced cell death, there are few studies focus-
ing on the effects of hyperoxia, either by itself or together
with hypoxia.
The sphingolipid ceramide is an important second signal
molecule that regulates diverse signaling pathways involv-
ing cell growth and differentiation, gene transcription,
viral replication, ligand binding, and cell death [11]. For
the most part, ceramide's effects are antagonistic to
growth and survival. Ceramide has been shown to play a
regulatory role in apoptosis induced by cytokines, DNA
injury, and other forms of cell stress [11-13]. In response
to exposure to stress, cells activate pathways that result in
the accumulation of cellular ceramide. Depending on the
cell type and the level of injury, the accumulated ceramide
can either induce cell cycle arrest by activation of the retin-
oblastoma protein, or induce apoptosis by a Bcl-2-regu-
lated mechanism [14-16]. The effects of hyperoxia on
ceramide levels have not been studied although hyperoxia
decreases sphingomyelin levels in surfactant without
affecting the activity of serine palmitoyl transferase, the
first enzyme in de novo ceramide synthesis [17]. In this
study, we determine the effects of exposure of rat neonates
to hyperoxia for a period of one week on the levels of cera-
mide and the correlation with apoptosis and expression of
Bcl-2 and Bax.
Methodology
Experimental design
Between 2 and 4 hours following birth, rat pups were dis-
tributed to litters of ten of equal body weight and nested
on softwood shavings in plexiglass exposure chambers.
They were assigned to receive either high oxygen concen-
tration or room air. Food and water were made available
ad libitum, and lighting provided on a 12-hr light/dark
cycle. Room and chamber temperature were maintained
at 22–24°C. Animals received care according to "the
Guide for the Care and use of Laboratory Animals of the
National Academy of Science and the Principles of Labo-
ratory Animal Care of the National Society of Medical
Research". The chambers were equipped with a flow-
through system for controlling the delivery of either med-
ical oxygen or room air. Six liters per minute of medical
oxygen were flowed through the hyperoxic exposure
chambers and oxygen concentration was monitored con-
tinuously using an oxygen monitor (Ohmeda 5120, Dou-
isville, CO) to be maintained at 95 ± 2%. In the control
chambers, the oxygen concentration was maintained at 21
± 2%. Carbon dioxide concentrations were maintained at
0.3%, and relative humidity between 50 and 80%. Moth-
ers were switched daily between hyperoxic and room air
chambers to prevent maternal oxygen toxicity. At the end
of postnatal day 7, hyperoxia-exposed pups were weaned
to room air by lowering the oxygen concentration to 60%
for 4 hours, to 40% for 4 hours and then to room air. At
birth and on postnatal days 3, 7, and 14, all pups were
weighed and two from each litter were arbitrarily selected,
anesthetized with pentobarbital (50 mg/kg) and their
lungs excised.
Tissue processing
The lungs were excised. The two left lobes were processed
and fixed in 4% buffered formalin. After 48 hours of fixa-
tion in formalin, the left lobes were paraffin embedded.Respiratory Research 2006, 7:100 http://respiratory-research.com/content/7/1/100
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The right lobes were divided into three specimens. The
first specimen was fixed in methanol and was homoge-
nized (Brinkmann Homogenizer model PT 10/35, Swit-
zerland). 400 μl of the homogenate was measured and 2
ml methanol, 1 ml chloroform was added and saved at -
80°C. The second specimen was homogenized and stored
in Sucrose-HEPES-Tris Cl (SHT) buffer. The second speci-
men was utilized for Ceramidase and sphingomylinase
assays. The third specimen was frozen in liquid nitrogen
and utilized later for RT-PCR for expression of IL-1β.
1. Morphological changes of apoptosis
A. Confocal microscopy
To correlate chromatin alteration with the presence or
absence of dUTP labeling, histologic sections were ana-
lyzed by fluorescence microscopy. Sections were fixed,
subjected to FITC-conjugated TUNEL (Boehringer Man-
nheim, Germany) assay and then scanned for signal using
488 nm excitation line from the Zeiss LSM 410 laser scan-
ning confocal microscope. Images were reconstructed and
examined for apoptosis.
B. TUNEL assay
The terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling (TUNEL) assay was used to mon-
itor the extent of DNA fragmentation as a measure of
apoptosis in paraffin-embedded sections. The assay was
performed according to the recommendations of the
manufacturer (Boehringer Mannheim, Germany). Using
paraffin sections that were 3 μm thick, the TUNEL assay
was performed as described previously [18]. Fluorescein-
conjugated dUTP incorporated in nucleotide polymers
was detected and quantified using fluorescence micros-
copy (Zeiss LSM 410, Germany). Positive and negative
controls were used to verify the specificity of the TUNEL
assay. Positive controls were treated with DNase I (Sigma
Chemical Co.) to enzymatically induce DNA fragmenta-
tion. TUNEL-positive nuclei were distinguished from the
TUNEL-negative nuclei by counter staining with Hoechst
stain and were counted after being photographed.
Lung sections were incubated and stained and the nuclei
were visualized. Tissues were then counterstained with
Hoechst (Molecular Probes, Eugene, OR). The number of
TUNEL positive cells was counted versus the total number
of cells labeled by the Hoechst stain. The apoptotic index
was calculated by dividing the number of TUNEL positive
to the total number of cells. An apoptotic score from 0 to
4 was also derived whereby 0 indicates 0% TUNEL posi-
tive cells, 1 indicates 1–25%, 2 indicates 25–50%, 3 indi-
cates 50–75%, and 4 indicates 75–100%.
2. Determination of ceramide levels
A. Lipid extraction
Lipids were extracted by the method of Bligh and Dyer
[19]. Briefly, cell membranes were extracted with 3 ml of
chloroform/methanol (1/2). The monophase was mixed,
then water was added and the samples rested for 10 min-
utes. The organic and aqueous phases were subsequently
separated by addition of 1 ml of chloroform and 1 ml of
water followed by vigorous shaking and centrifugation at
200×. The organic phase was carefully removed and trans-
ferred to a new tube and the sample dried under nitrogen.
Lipids were then resuspended in 1 ml of chloroform.
B. Ceramide measurement
Ceramide levels were measured using a modified diacylg-
lycerol kinase assay using external standards [20]. In this
assay, 80% of the lipid sample was dried under nitrogen.
The dried lipid was solubilized in octyl-β-D-glucoside/
dioleoyl phosphatidylglycerol micellar solution (7.5%
octyl-β-D-glucoside, 25 mM dioleoyl phosphatidylglyc-
erol) by 2 cycles of sonication in a bath sonicator, fol-
lowed by resting at room temperature for 15–20 minutes.
The reaction buffer containing 100 mM imidazole HCl,
pH 6.6, 100 mM LiCl, 25 mM MgCl2, 2 mM EGTA, was
added to the lipid micelles, in the presence of 0.2 μl of 1
M dithiothreitol, 5 μg of diglycerol kinase membranes,
and dilution buffer (10 mM imidazole, pH 6.6, 1 mM
diethylenetriaminepentaacetic acid, pH 7) to a final vol-
ume of 90 μl. The reaction was started by adding (γ32P)
ATP solution and allowed to proceed at 25°C for 30 min-
utes. Lipids were extracted as described above and a 1.5 ml
aliquot of the organic phase dried under nitrogen.
Lipids were then resuspended in methanol/chloroform
(1/20) and 20 μl were spotted on a 20 cm silica gel thin
layer chromatography plate. Plates were developed with
chloroform: acetone: methanol: acetic acid: water
(50:20:15:10:5), air dried, and subjected to autoradiogra-
phy. The radioactive spots corresponding to ceramide-
phosphate, the phosphorylated product of ceramide were
scraped into a scintillation vial and counted on a scintilla-
tion counter. Linear curves of phosphorylation were pro-
duced over a concentration range of 0–640 pM of external
standards (dioleoyl glycerol and C-III ceramide, Sigma).
DAG and ceramide levels were normalized to lipid phos-
phate.
C. Lipid phosphate measurement
Lipid phosphates were measured according to the method
of Rouser et al [20]. Briefly, 20% of the lipid sample was
dried under nitrogen and oxidized with 70% perchloric
acid on a heating block at 160°C for 45 minutes. The
tubes were allowed to cool then water was added, fol-
lowed by 2.5% ammonium molybdate, and 10% ascorbic
acid with vortexing after each addition. The tubes wereRespiratory Research 2006, 7:100 http://respiratory-research.com/content/7/1/100
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then incubated at 50°C for 15 minutes, allowed to cool,
and absorbency read at 820 nm and compared to stand-
ards.
3. Sphingomyelinase assay
Specimen from lung tissue stored in Sucrose-HEPES-Tris
Cl (SHT) buffer was subjected to homogenization with
22G1/2 syringe followed with 27 G1/2 needle.
The activity of Acid SMase (A-SMase) was determined
using a mixed micelle assay system. 10 μg of protein was
mixed with a reaction mixture containing 10 nmol of
[14C]Sphingomyelin (100,000 dpm) resuspended in 100
mM Sodium acetate, pH 4.5 and 0.1% Triton X-100 in a
total volume of 100 μl. The reaction was incubated for 30
minutes at 37°C in shaking water bath and then was ter-
minated by the addition of 200 μl of H2O. After phase
separation, 300 μl of the upper phase containing the enzy-
matically released N-[14CH3]phosphocholine was
counted in a liquid scintillation counter.
4. Ceramidase assay
Specimen from lung tissue stored in Sucrose-HEPES-Tris
Cl (SHT) buffer was subjected to fractionation in 25 mM
and 100 mM Tris-Cl (pH 7.4), 100 mM Tris-CL (pH 9)
and 0.5 M NaAc (pH 4.5). The collected membranes were
then sonicated and subjected to the ceramidase assay.
Ceramidase activity was determined in an assay mixture of
NBD C12-ceramide and Triton X-100 at final concentra-
tion of 100 μM and 0.3% respectively, in 0.5 M sodium
acetate buffer, pH 4.5 (for acidic enzyme), 100 mM Tris-
Cl buffer, pH 7.4 (for the neutral activity) and 100 mM
Tris-Cl buffer, pH 9 (for the alkaline enzyme). The reac-
tion was carried using 100 μg of protein in 50 μl of the
specified buffer and mixed with 50 μl of the substrate.
Samples were then incubated at 37°C in shaking water
bath for 1 hour. The reaction was terminated by the addi-
tion of 300 μl chloroform/methanol (1:1, v/v) followed
by vortexing and centrifugation at 2500 g for 10 minutes.
150 μl of the lower phase was transferred to a new micro-
centrifuge tube and dried. Samples were then resuspended
in 40 μl chloroform and 35 μl was spotted on TLC and ran
in chloroform/methanol/NH4OH (6.4 N) (90:30:0.5, v/
v/v) for 1 hour. After air drying the plates were scanned on
phosphoimager and the observed bands were quantified.
5. Bcl-2 and Bax expression
Tissue sections from normal and hyperoxic animals were
incubated in 10 mM sodium citrate buffer, pH 6.0 at 95°C
for 5 min and repeated two times. Slides were then
allowed to cool in the buffer for 20 min and then washed
in deionized water for two minutes and repeated three
times. After the procedure of antigen unmasking is
through, specimens were incubated in 1.5% goat serum
followed by anti-Bcl-2 peptide antiserum or anti-Bax pep-
tide antibodies (Santa Cruz Biotechnology). Slides were
counterstained with propidium iodide. Bcl-2 and Bax
immunostains were scored from 0 to 4, whereby 0 indi-
cates 0% Bcl-2 and Bax positive cells, 1 indicates 1–25%,
2 indicates 25–50%, 3 indicates 50–75%, and 4 indicates
75–100%. Mod K cells were already reported to express
Bax and were used as positive control for Bax immunos-
tains and were scored 4. MCF 7 cells transfected with Bcl-
2 were used as positive controls because of overexpression
of Bcl-2 immunostains. MCF 7 cells were also scored 4 as
well [21,22]. Pictures from endothelial, bronchial and
alveolar areas were obtained and scored individually. The
average score was then calculated.
6. E-Cadherin immunostaining and Hoechst staining
Antigen retrieval for tissue sections from control and
hyperoxic animals was performed as described before for
Bax and Bcl-2 immunostaining. The specimens were then
incubated for 1 hr in 0.2% Triton-X-100 (for permeabili-
zation) diluted in 3% normal goat serum, followed by 2
hrs incubation in E-cadherin antibody (Chemicon Inter-
national, USA) diluted 1:500 in 1.5% normal goat serum.
Thenafter, slides were incubated for 1 hr in FITC-conju-
cated secondary antibody. After several washes, tissues
were counterstained with Hoechst staining. Hoechst (10
mg/ml) was diluted to 1 μg/ml, in which slides were incu-
bated for 5 minutes, and then washed in phosphate buff-
ered saline (PBS) for 45 minutes.
7. IL-1β expression
Total RNA was extracted from lung tissues preserved in
liquid nitrogen according to the manufacturer using the
MN Nucleospin® RNA II extraction kit (Macherey-Nagel
GmbH Co.KG, Düren, Germany). Reverse-Transcriptase
PCR (RT-PCR) from the RNA template (1 μg) was per-
formed according to the manufacturer using the Reverse-
iT™ One-Step RT-PCR Kit (ABgene, Surrey, UK). Specific
primers were used to detect the IL-1β as the β-actin gene
for normalization purposes (figure 6A).
Statistical assessments
Differences were considered significant for p < 0.05 in
comparing two measurements. Comparison among
groups was evaluated by analysis of variance (ANOVA).
The Kruskall-Wallis test was used to compare apoptotic
index scores.
Results
All rats survived the 7 days of hyperoxia. 50% mortality
was observed by day 14 in the subgroup of animals that
were exposed to 7 days of hyperoxia and were then placed
in room air for additional 7 days. In addition, the pups
that survived the 14 days appeared ill and weak. There was
no statistically significant difference in body weights ofRespiratory Research 2006, 7:100 http://respiratory-research.com/content/7/1/100
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the different animal groups when compared to controls
(figure 1A). Lung weights showed no difference between
the different control and hyperoxia group except for day 7
(Figure 1B); the hyperoxia-exposed group at day 7
weighed less than the control group.
To determine the role of the sphingolipid ceramide in
hyperoxia, ceramide levels in lung tissue were measured
and found to be 3.10 pmole/nmole phosphate (pmole/
nmnmole Pi) and 2.26 pmole/nmole Pi on day 3, 2.82
pm/nmPi and 2.58 pm/nmPi on day 7 and 4.66 pm/nmPi
and 2.91 pm/nmPi on day 14 in hyperoxia-exposed rats
and control rats, respectively. The differences on days 3
and 14 were statistically significant (p < 0.01) (Figure 2A).
The pathways of ceramide up-regulation include de novo
synthesis, sphingomyelinase activation, or inhibition of
ceramide catabolism. Investigation of de novo synthesis of
ceramide in an animal model is technically difficult
because the most acceptable assay is the demonstration of
radioactively-labeled palmitate incorporation into cera-
mide that is newly synthesized from the condensation of
serine and palmitate. The amounts of radioactive palmi-
tate that would be required are too large for the conduct
of a safe experiment in this model. Also, measurement of
ceramide synthase, the enzyme that is most important in
de novo ceramide synthesis is exceedingly difficult in the
setting of homogenized animal tissue. However, we were
able to measure sphingomyelinase activity and found no
change in the enzyme's activity in response to hyperoxia.
Ceramidase(s) acidic, neutral or alkaline activity was also
measured and also did not show any increased activity at
the different time points when compared to the control
groups. These findings suggest that neither sphingomyeli-
nases nor ceramidases are involved in ceramide genera-
tion in the setting of hyperoxia. This raises the possibility
that de novo synthesis is likely to be the mechanism by
which ceramide accumulates in our model.
The role of Bcl-2 family of proteins was evaluated by the
measurement of the anti-apoptotic protein Bcl-2 and the
pro-apoptotic protein Bax. As explained in Methods, the
expression of Bcl-2 was scored and was found to be 4 and
0.71 at day 3, 1 and 0.735 at day 7 and 3.33 and 1.38 at
day 14 in the hyperoxia-exposed rats and the control rats,
respectively The differences at days 3 and 14 were statisti-
cally significant (Figure 2B). As for Bax, the expression was
4 and 0.86 on day 3, 1.71 and 1.50 on day 7 and 2.75 and
1.07 on day 14 in the hyperoxia-exposed and control rats,
respectively. The difference at day 3 and 14 was statisti-
cally significant (Figure 2C).
TUNEL staining was used to determine the level of apop-
tosis in experimental and control rats and to generate an
apoptotic index, which was 0.65 for the lungs of hyper-
oxia-exposed rats at 3 days. The difference at 3 days was
statistically significant (p < 0.001). Hoechst staining pro-
vided further evidence that apoptosis did occur at 3 days.
The observation of relatively small and densely Hoechst-
stained nuclei suggests that cells are apoptotic. To deter-
mine the histolology of cells undergoing apoptosis, E-cad-
herin immunostaining was performed. Cadherins
constitute a family of transmembrane glycoproteins that
are involved in Ca2+-dependent cell-cell interactions. They
Body and lung weight changes of animals exposed to hyperoxia vs controls Figure 1
Body and lung weight changes of animals exposed to hyperoxia vs controls. 
* is placed where the difference is statistically significant. 
A) Body weights of the control vs. the hyperoxia animal group at 0, 3, 7 and 14 days. 
B) Lung weights of the control vs. the hyperoxia animal group at 0, 3, 7 and 14 days.
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function in the maintenance of tissue integrity and mor-
phogenesis [23]. E-cadherin is the predominant subclass
that has been identified in most types of epithelial cells
including lung epithelial cells, where it is closely associ-
ated with the adhesion belts of the adhering junctional
complexes [24]. Hoechst staining, on the other hand, is
utilized to document apoptosis by visualizing chromatin
condensation and nuclear shrinkage followed by the for-
mation of apoptotic bodies. By performing both (E-cad-
herin and Hoechst) stains simultaneously, we were able to
demonstrate: a) that apoptosis occurred predominantly at
3 days and b) the main cells undergoing apoptosis were
epithelial cells as they stained positive by E-cadherin anti-
body. (figure 3B and 3C).
To evaluate the pathologic changes in response to hyper-
oxia, sections of lung tissue from control and hyperoxia-
exposed rats were Hematoxylin and Eosin stained and
examined by light microscopy. There were significant and
striking differences. Most notably there was expansion
and dilatation of the alveolar ducts and the ventilatory
units including the air sacs. There was no apparent signif-
icant difference at day 3 but it became most exaggerated at
day 7 (figure 4). The effect was sustained at day 14 but to
a lesser degree. Over the course of the experiment, there
was progressive thinning of the alveolar interstitial wall.
At day 14, the density of the capillaries was the highest
and in the hyperoxic-exposed rats, there was more mar-
ginating neutrophils and their number was increased
when compared to the control group (Figure 5). There was
no evidence of hemorrhage, hyaline membrane forma-
tion or coagulative necrosis.
The role of the inflammatory mediators in our model of
lung injury was evaluated by measurement of IL-1β
expression via Reverse-Transcriptase PCR (RT-PCR)
Changes in apoptosis, ceramide, Bcl-2 and Bax  of neonatal lungs exposed to hyperoxia Figure 2
Changes in apoptosis, ceramide, Bcl-2 and Bax  of neonatal lungs exposed to hyperoxia. 
* is placed where the difference is statistically significant. 
A) Apoptotic scores in the whole lung of the control vs. the hyperoxia animal group at 0, 3, 7 and 14 days. 
B) Ceramide/ phosphpate ratio levels of the control vs. the hyperoxia animal group at 0, 3, 7 and 14 days. 
C) Scores of immunostains in the whole lung of the control vs. the hyperoxia animal group at 0, 3, 7 and 14 days.
D) Scores of immunostains in the whole lung of the control vs. the hyperoxia animal group at 0, 3, 7 and 14 days.
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method. β-actin gene expression was also evaluated as a
control. There was an observable increase of band inten-
sity for the IL-1 β gene at day 14 suggesting an increase in
the inflammatory mediators expression in the hyperoxia
groups compared to the control groups (Figure 6B).
Discussion
Ceramide generation is an important step in the signaling
cascades that lead to apoptosis. Ceramide is a sphingomy-
elin breakdown product that has not been studied in
hyperoxia-induced lung injury. In this study, we exam-
ined the interplay of ceramide, Bax and Bcl-2 in a well-
established model of hyperoxia-induced lung injury in the
newborn rat [25,26]. Our study demonstrated overexpres-
sion of ceramide in neonatal lungs after 3 days of expo-
sure to hyperoxia. Ceramide generation is usually by: a)
The hydrolysis of membrane sphingomeylin via the activ-
ity of sphingomyelinases, b) The inhibition of cerami-
dases which hydrolyze ceramide to sphingosine and fatty
acids, or c) by activation or de novo synthesis [11,13]. In
our experiments, acidic sphingomyelinase did not change
in response to hyperoxia at the three time-points exam-
ined, i.e. 3, 7, and 14 days. Also, ceramidase(s) activity did
not change as well. These findings suggest that de novo
synthesis is the likely mechanism by which ceramide
accumulated in our animal model. Further testing of de
novo synthesis for ceramide generation is technically diffi-
cult in an animal model. The significantly high levels of
ceramide correlated with an increase in apoptosis as deter-
mined by TUNEL assay and an overexpression of Bax in
hyperoxia-exposed lungs. The corresponding sections of
the neonatal lungs after three days of hyperoxia did not
demonstrate any evidence of cellular necrosis or loss of
architecture of the lung parenchyma (Figure 3). This sug-
gests that after 3 days of hyperoxia, cellular death occurs
via apoptosis. Previous studies have shown similar results
in the first 48–72 hours of hyperoxia. Kazzaz et al noted
that in contrast to direct exposure of cells in culture to
hyperoxia, apoptosis was clearly induced in the lungs of
hyperoxic mice after 48 hours of hyperoxia [27]. Simi-
larly, McGrath-Morrow et al demonstrated, after 3.5 days
of high concentrations of oxygen, an increase in apoptosis
in the peripheral lung of neonatal mice [28]. The increase
in apoptosis was associated with an induction of Bax
mRNA expression as well.
Bax appears to be a key activator of ceramide-mediated
death pathways. Von Haefen et al demonstrated that cera-
mide-induced apoptosis is marginal in Bax-negative DU
145 cells. Reconstitution of Bax restored ceramide-
induced apoptosis [29]. Buccellato et al. demonstrated
that hyperoxia resulted in Bax activation at the mitochon-
drial membrane and subsequent cytochrome c release
[30]. Pagano et al observed a progressive release of cyto-
chrome c from the mitochondria into the cytosol of alve-
olar cells, following hyperoxic exposure. This release was
accompanied by the translocation of the proapoptotic
protein Bax [31]. The mechanism of the response of the
E-Cadherin and Hoechst Staining of neonatal lung after 3 days of Hyperoxia Figure 3
E-Cadherin and Hoechst Staining of neonatal lung after 3 days of Hyperoxia. A, B, and C correspond to the same section of the 
examined tissue. Bar corresponds to 40 μm. A. Hoechst stained cells are noted and the white arrows are pointing at cells with 
apoptotic nuclei. B. E-Cadherin stained cells. C. An overlay of Hoechst and E-Cadherin, arrows indicate the dense apoptotic 
nuclei surrounded by E-cadherin (halo) staining.Respiratory Research 2006, 7:100 http://respiratory-research.com/content/7/1/100
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Histological findings of neonatal lungs in the presence of hyperoxia Figure 4
Histological findings of neonatal lungs in the presence of hyperoxia. Photomicrographs of lung tissue from control (C) and 
hyperoxia-exposed (H) rats at 3, 7, and 14 days. While normal development and alveolarization is seen in the control group, 
the hyperoxia exposed group shows significant dilatation and expansion of the alveolar ducts and the ventilatory units. The 
changes are most prominent at day 7 and regress at day 14. (Hematoxylin and Eosin × 10).Respiratory Research 2006, 7:100 http://respiratory-research.com/content/7/1/100
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Bcl-2 family of proteins to hyperoxia is thought to start
with the release of cytochrome c from the intermembrane
space into the cytosol accompanied by depolarization of
the mitochondrial membrane potential. The release of
cytochrome c leads to caspase 9 activation and the com-
mitment of the cell to die. Apoptotic stimuli cause trans-
location of Bax from the cytosol to the mitochondria,
where it causes membrane permeabilization. Anti-apop-
totic proteins (Bcl-2, Bcl-x) prevent changes in the mito-
chondrial membrane potential. Antiapoptotic members
of the Bcl-2 family inhibit membrane permeabilization by
sequestering or inhibiting Bax and Bak. Interestingly, both
ceramide and Bcl-2 family members appear to target the
mitochondria.
At 7 days of age and after continuous exposure to hyper-
oxia, ceramide returned to baseline levels. This was
accompanied by reduction in Bax and Bcl-2 expression to
baseline levels and absence of apoptotic changes. The lack
of apoptosis may represent adaptation of the animals to
hyperoxia and/or it may represent a quiescence phase
where the animals have managed to contain the initial
hyperoxic injury. However morphologically, the lung tis-
sue showed exaggerated expansion and dilation of the
alveolar ducts and ventilatory units. Early margination of
neutrophils within the capillaries of the interstitial wall is
also noted. Jacqueline et al reported similar findings and
concluded that hyperoxia disrupts the coordinated prolif-
eration of the lung of neonates and, causes apoptosis of
specific cell types that are needed in the development of
the lungs of animals [32]. It appears that hyperoxia expo-
sure and apoptosis observed at day 3 may have contrib-
uted to the delay in lung maturation and produced
structural defects in the neonatal lungs of the hyperoxia
group as well [33].
At 14 days, one week after discontinuing hyperoxia, there
was another rise in ceramide without associated apopot-
otic changes. A rise in Bcl-2 and Bax was also noted along
with a change in the Bcl-2/bax ratio to favor Bcl-2. The
lack of apoptosis at this point may result from the inter-
play of ceramide, a proapoptotic modulator, with Bcl-2,
known to have antiapoptotic activity. The relationship
between Bax and antiapoptotic proteins of the Bcl-2 fam-
ily may also determine apoptosis [34-36]. Sawda et al, for
example, demonstrated that the exposure of C6 glioma
cells to etoposide resulted in apoptosis, increased forma-
tion of ceramide and a decreased expression of Bcl-2 with
reciprocal increase in Bax protein. Reducing ceramide for-
mation, prevented apoptosis and resulted in a change of
the Bax/Bcl-2 ratio to favor Bcl-2 [37]. This indicates that
ceramide's apoptotic effects maybe partially through its
effects on Bax/Bcl-2 ratio.
The interaction between the Bcl-2 family of proteins and
ceramide can be upstream or down stream. Without
blocking ceramide accumulation, Bcl-2 has been shown
to block ceramide-induced apoptosis. Vincristine, for
example, increases ceramide levels in the presence of over-
expressed Bcl-2 without apoptosis. This indicates that Bcl-
2 anti-apoptotic effects act downstream of ceramide. The
interaction of ceramide and Bcl-2, however, appears to be
more complex: In the same cell type, Molt-4 cells, cera-
mide accumulation is induced by γ-irradiation, but this
accumulation is prevented by Bcl-2 overexpression, indi-
cating that Bcl-2 may function upstream as well [16].
In our study, there was an increase in Bax occurring at 3
days of age. This increase correlated with the apoptotic
changes documented by TUNEL. Bcl-2 was elevated at 3
and 14 days. The Bcl-2 to Bax ratio (1, 0.58 and 1.21 at
days 3, 7 and 14 respectively) did not appear to correlate
with the apoptotic changes.
The rise of ceramide, Bax, and Bcl-2 may also be secondary
to inflammation and lung injury. At 14 days, one week
after discontinuing hyperoxia exposure, 50% mortality
was noted and the animals that survived the experiment
appeared very ill. IL-1β activity was also significantly
increased at 14 days. It is evident that clear and irreversible
changes had occurred and inflammation leading to the
animals death. Lung tissue showed persistence of the
expansion and the dilatation of the alveolar spaces but to
a lesser degree when compared to day 7. However, there
was noticeable increase in the number of marginating
neutrophils in the capillaries of the interstitial wall when
compared to the day 7 group (Figure 5).
Acute lung injury after prolonged hyperoxia exposure Figure 5
Acute lung injury after prolonged hyperoxia exposure. Phot-
omicrograph of the interstitial wall of a hyperoxia-exposed 
rat at day 14 showing the prominent margination of neu-
trophils in the capillaries (Hematoxylin and Eosin × 40).Respiratory Research 2006, 7:100 http://respiratory-research.com/content/7/1/100
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Those findings suggest that prolonged hyperoxia in new-
borns can cause delayed lung damage characterized earlier
by margination of neutrophils and later by interstitial and
intra-alveolar edema. Hyperoxia may have also triggered
proinflammatory cytokines and a cascade of events that
lead to influx of neutrophils and irreversible lung injury.
This has occurred even after placing the animals in room
air for more than a week.
In conclusion, our study suggests that the effects of hyper-
oxia on the lung are time sensitive processes that include
initial and delayed response. In our study, the initial
response is characterized by a rise in ceramide, Bax and
Bcl-2 leading to apoptosis. No evidence of inflammatory
process is noted at this stage. In the delayed phase, no
apoptosis was detected and the late phase is acute lung
injury with influx of neutrophils and inflammatory
response. No apoptosis is noted and the rise in Ceramide,
Bax and Bcl-2 may be due to the inflammatory process.
Apoptosis noted in the initial phase may then be an
appropriate response through which damaged cells are
removed without triggering an acute inflammatory reac-
tion. As apoptosis is switched off, inflammatory process is
activated leading to acute lung injury and death. We rec-
ommend further time points and experiments to deline-
ate further the effects of hyperoxia. This will help us in
planning interventions in a timely manner to counter the
effects of hyperoxia and acute lung injury.
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